気管支肺胞洗浄液中に一過性の好中球増多をきたしたアトピー型喘息 by Tanizaki, Yoshiro et al.
52 Bronchoalveolar neutrophilia in asthma
Transient bronchoalveolar neutrophilia m
a patient with atopic asthma
Yoshiro Tanizaki, Hikaru Kitani, Takashi Mifune
Fumihiro Mitsunobu, Kazuhiro Kajimoto, Keisuke
Sugimoto, Satoshi Yokota, Junichi Hiramatsu,
Masashi Kawaraya, Yoshiyasu Nakagiri I), Shinya
Tada2) and Ikuro Kimura2)
Division of Medicine, 1) Gynecology, Misasa Medical
Branch, 2)Second Department of Medicine, Okayama
University Medical school
Abstract: Clinical course of one asthma patient (64 years old, female), who had an
increased proportion of neutrophi Is in bronchoalveolar lavage (BAL) fluid, was observed
in relation to the proportion of BAL cells and ventilatory function. The patient had
large asthma attacks two times during her clinical course for 15 months observed. 1. An
increased proportion of BAL neutrophi Is and suppression of venti latory function were
found after her first large asthma attacks. The increased proportion of BAL neutrophi Is
continued for more than 5 months. A reduction in the proportion of BAL neutrophils
was found 3 months after her second large asthma attack, accompanied by improvement
of clinical symptoms and ventilatory function. The numbers of total cells and
neutrophils in BAL fluid were also reduced. Transient increase in number of BAL
lymphocytes was found 13 months after the first large attack when the number of BAL
neutrophils was markedly decreased. The number of BAL eosinophils did not change
during her cl inical course.
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Introduction
Recently, airway inflammation m patients
with bronchial asthma has been noted as a
major mechanism causing asthma attacks. In
the inflammatory process, lymphocytes,
neutrophils, eoosinophils, and basophils,
which migrate from the bloodstream, play
their important roles in the mechanism of
onset of the disease (1-7). Of these cells,
lymphocytes, eosinophils and basophils have
been clarified to participate in pathophy-
siological changes in the airways of asthma,
since these cells are activated in allergic
Bronchoalveolar neutrophilia in asthma 53
Table 1. Allergo-immunological examinationsreaction sites and release lymphokines or
chemical mediators (8 -13). However, it IS
still uncear whether neutrophils in the air-
ways participate in the mechanism of onset
of asthma. Our previous studies have shown
that an increased proportion of neutrophils in
bronchoalveolar lavage (BAL) fluid was
sometimes found in patients with asthma,
particularly in those with steroid-dependent
intractable aasthma (SDIA) (14,15). Our
studies have also demonstrated that an In-
creased proportion of BAL neutrophils in
asthma patients is closely related to long-
term glucocorticoid therapy (15).
In the present study, clinical characteristics
of a patient who showed transient increase in
the proportin of BAL neutrophils were exam-
ined in relation to clinical symptoms, the
proportion of BAL cells, and ventilatory
function.
Immunoglobulins
IgE 504 IU!m4
IgG 1388mg/dt
IgA 381mg/dt
IgM 67mg/dt
RAST score
House dust 1 2+
Mitel 3+
Candida 0+
Skin test
House dust +
Japanese Cedar +
Silk +
Candida
Lympocyte subsets
CD4 52%
CD8 20%
CD4/8ratio 2.6
Blood cells
RBC 398XW/cmm
Hb 12.2g/dt
WBC 10600/cmm
St 29%
Sg 53%
Lym 13%
Mo 5%
Eo 0%
Ba 0%
Case report
The patient was 64 years old, female, with
atopic asthma. She had had asthma attacks,
but not large, for 2 years before she was
admitted to Katsuyama hospital (which was
located at north side of Okayama prefecture)
on April 7, 1988, because of her first large
attack. On her admission to the hospital,
she had various examinations for her asthma.
The results of allergo-immunological exami-
nations were shown in Table 1 : she was
evaluated as atopic asthma, because the level
of serum IgE was high and IgE antibodies to
house dust mite was found in her serum.
However, peripheral eosinophilia was not
found on her admission.
When she was admitted to the hospital, she
had large asthma attack in which breath
sound were markedly decreased and moist
rales (bubbling) were heard over both lower
lung fields on auscultation. She complained
of marked dyspnea and recurrent cough all
day long, particularly at night. Clinical and
laboratory findings on her admission, fever,
yellowish sputum, increased number of pe-
ripheral neutropphils and a high value of
CRP (13.5 rug / d£), showed that she had
respiratory infection. Thus, she was treated
with antibiotics, expectorants, broncho-
dilators and glucocorticoids. Her symptoms
and laboratory findings were markedly im-
proved 2 months after her admission and she
was discharged on July 15, 1988. After then
she had slight respiratory infection, which
induced her second large asthma attack. Then
she was admitted to our hospital, as shown
in Fig. 1.
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had never asthma attacks after her second
large asthma attack. The fourth BAL exami-
nation was carried out 4 months after her
second large asthma attack (one month after
the third BAL examination). The proportion
of each BAL cell in this examination was
58.0% macrophages, 36.2% lymphocytes, 5.6
% neutrophils and 0.2% eosinophils These
results show that reduction in the proportion
of BAL neutrophils, which was accompanied
by increase in the proportion of BAL lympho-
cytes, was found during her clinical course
(Fig. 2).
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Fig. 1. Clinical course of the patient with
atopic asthma (64 years old, fe-
male). The patient had large asthma
attacks two times during her clinical
course for 15 months observed. BAL
Total cell number in BAL fluid was also
reduced as the proportion of BAL neutrophils
decreased, as shown in Table 2. The number
of BAL lymphocytes was increased at the
third BAL examination. The number of BAL
neutrophils was reduced at the second BAL
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Fig. 2. Changes in the proportion of each
BAL cell of the patient (64 years old,
female) during her clinical course for
15 months observed. An increased
proportion of BAL neutrophils was
observed at the first and second BAL
examination. After then the propor-
tion of BAL neutrophils decreased
and the proportion of BAL lympho-
cytes tended to increase. (c==J)
macrophages, (~) lymphocytes,
(.) neutrophils, (IDBID eosinophils.
examinations and ventilatory func-
tion tests were performed four times,
as shown by the number in parenthe-
SIS.
SAL examination
Bronchoalveolar lavage (BAL) was per-
formed four times during all her clinical
course after her first large asthma attack, by
a previously reported method (14 -16). The
proportion of BAL cells 2 months after her
first large asthma attack was as follows :
33.0% macophages, 10.4% lymphocytes, 56.2
% neutrophils, 0.2% eosinophils, and 0.2%
basophils. The results showed marked increase
in the proportion of BAL neutrophils. The
second BAL examination was performed 7
months after her first large asthma attack.
Although she was free of attacks at that
time, the second BAL examination results
still showed marked increase in the propor-
tion of BAL neutrophils. In the third BAL
examination, which was performed 3 months
after her second large asthma attack, the
proportion of BAL neutrophils was markedly
decreased : 45.2% macrophages, 48.6% lym-
phocytes, 5.6% neutrophils, and 0.6% eosin-
ophils. Her clinical course was good and she
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examination, and markedly reduced at the
third and fourth BAL examination. The
number of BAL eosinophils did not change
during all her clinical course (Table 2).
Table 2. Total cell number and number of
each cell in bronchoalveolar lavage
(BAL) fluid
Total cell number BAL celIe (xl0 4/ml)
BAr;
exa.lnation (x106 , (xl04 /ml) Mac Lp Neut E08
/ sec in V25 in the third ventilatory function
tests which were performed 3 months after
her second large asthma attack. The values
of each ventilatory parameter were clearly
improved 4 months after her second large
asthma attack: 2.42 £ (+5.2%, compared to
the value in the first ventilatory function
tests) in FVC, 1.73 £ (+35.2%) in FEV1.0,
4.65 £ / sec (+36.4 %) in PEFR, 1.56 £ / sec
(+92.6%) in Vso and 0.83 £ /sec (+219.2%)
in V2S, as shown in Fig. 3.
1. 'June 20,
1988 18.8 31.3 10.3 3.3 17.6 0.1
2. Nove_ber 2.5 • 5.0
14, 1988 18.6 25.8 12.8 2.0 10.9 0.1
---
..........
3. AprilS, 2.0 4.0 ;ll
1989 12.3 12.4 5.6 6.0 0.7 0.1
4. June 6, ~
===-
~ :II
1989 9.9 7,4 4.2 2.7 0.4 O. I ~1.5 3.0 fO
..
::I
Mac, _crophages; Lynt, lYMphocytes; "eut r neutrophile: ~ 1.0 2.0 ~.IVBos, eoeinophl1s. 0 /it 0.5 D 1.0 t0-
.,..--w e.-
n IfVentilatory function
Ventilatory function tests, using a Box
8piror 81-8 (Chest Co.), were carried out 4
times when she was free of attacks. In the
first ventilatory function tests, which were
performed 2 months after her first large
asthma attack, the values of each ventilatory
parameter were 2.30 £ in FVC, 1.28 £ in
FEV1.0, 3.41£ / sec in PEFR, 0.81£ / sec in
V50 and 0.26 £ /sec in V25' respectively, dem-
onstrating marked decrease in the values of
. .
FEV1.0, V50 and V25. The results in the second
ventilatory function tests (performed 7
months after her first large asthma attack)
were similar to those in the first ventilatory
function tests. These obstructive ventilatory
dysfunction gradually improved as the pro-
portion of BAL neutrophils decreased. The
values of each ventilatory paramenter were
2.33£ in FVC, 1.58 £ / sec in FEV1.0, 3.92.e
/ sec in PEFR, 1.07 £ / sec in V50 and 0.35 £
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Fig. 3. Improvement of ventilatory function
of the patient (64 years old, female)
during her clinical course for 15
months observed. Percent improve-
ment of each ventilatory parameter
compared to the initial value after
her first large asthma attack was
+5.2% in FVC (.-e), +35.2% in
FEV 1.0 (0-0), + 36.4% in PEFR
(/:,-/:,) , +92.6% in V50 (0-0) and
+219.2% in V25 (x-x)
Discussion
Recently, airway inflammation has been
considered to be important in the mechanism
of asthma (1-7). It is necessary for inflam-
matory cells, which are observed in local
allergic reaction sites, to be activated to play
their roles. Of these inflammatory cells such
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as lymphocytes, eosinophils and basophils, all
cells except neutrophils have been shown to
be activated at local allergic reaction sites
and release lymphokines or chemical media-
tors (8 -13). However, there are no evidences
about activation of neutrophils in the air-
ways (11,17). Furthermore, although there
are a few reports about BAL neutrophilia in
bronchial asthma (18), clinical significance of
BAL neutrophils is unclear. Thus, it IS un-
clear whether neutrophils participate in the
mechanism of onset of asthma.
Table 3 shows 7 patients with bronchial
asthma who had an increased proportion of
BAL neutrophils (more than 50%). Case 1 in
Table 3 is the patient whose clinical course
was discussed in this study. The other
six patients with bronchial asthma had
glucocorticoid therapy for a long time. They
were evaluated as having steroid-dependent
Table 3. Asthma patients with BAL neutro-
phils of more than 50%
IgE Glucocorticoids
Patients
Age Sex (Iu/lt) RAST Dose Duration(HD) (mgjday) (years)
1oK·S. 64 F 5042+
2.S·B. 56 F 105 7.5 4
3.T·H. 45 M 233 12.5+K 15
4.M·T. 71 M 108 ..... 7.5 6
S.H·O. 56 M 1820 2+ 10.0 5
6.K·T. 52 M 65 20.0 12
7.T·F. 37 M 201 - 10.0+K 7
K: deposit type of glucocorticoids(Kenacort A®)
intractable asthma (SDlA), and their symp-
toms have not been improved. They always
require glucocorticoids for their asthma
attacks. In none of them, the proportion of
BAL neutrophils has not shown a tendency to
decrease despite long-term treatment includ-
ing glucocorticoids. In contrast, in case 1, the
proportion of BAL neutrophils was reduced
during her clinical course. Her symptoms and
ventilatory function were clearly improved
and she did not require glucocorticoids after
her second large asthma attack. Of the 7
patients with an increased proportion of BAL
neutrophils, as shown in Table 3, case 1 had
not SDlA and showed transient BAL
neutrophilia.
Our previous studies have demonstrated
that bronchial asthma is classified into three
clinical types : Ia. simple bronchoconstriction
type, lb. bronchoconstriction + hypersecretion
type, and n. bronchiolar obstruction type (19,
20). Of these clinical asthma types, type lb
asthma is characterized by increased propor-
tion of BAL eosinophils, and type n asthma
is characterized by increased proportion of
BAL neutrophils (14, 21-23). These findings
suggest that an increased number of BAL
neutrophils is closely related to clinical fea-
ture of type n asthma. Our previous studies
have also shown that an incrrease in the
proportion of BAL neutrophils is related to
long-term oral glucocorticoid therapy (15). In
these steroid-dependent intractable asthma,
persistent BAL neutrophilia may be induced
by long-time glucocorticoid regimen.
It was unclear in this study whether there
are some differences between mechanisms
causing transient and persistent BAL
neutrophilia. Further studies are necessary to
clarify mechanisms inducing BAL neutro-
philia.
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気管支肺胞洗浄液中に一過性の好中球増多をきた
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経過中に気管支肺胞洗浄 (BAL)液中に一過
性の好中球増多が観察されたアトピー型喋息症例
について,若干の臨床的観察を加えた｡症例は,
64才の女性で,臨床症状,および血清IgE高値,
ハウスダストに対するIgE抗体陽性などから,ア
59
トピー型鴨息と診断された｡なお,経過観察し得
た15カ月の間に2回の大発作が観察された｡
1.第1回の大発作後,BAL液中好中球増多
と換気機能の低下が観察された｡そして,この
BAL液中好中球頻度は明らかな改善が見られた｡
BAL液中の総細胞数および好中球の絶対数も徐々
に減少傾向を示し,好中球頻度と同様,第2回目
の大発作3カ月後には著明な減少が観察された｡
同時にこの時期には,BAL液中リンパ球の増加も
見られた｡しかし,BAL液中好酸球数は15カ月の
経過観察中ほとんど変化は見られなかった｡
キーワード:気管支喋息,一過性BAL液中好中球
増多,換気機能
